LOGIN  |  REGISTER

Recent Insider Transactions - Inhibikase Therapeutics (NASDAQ: IKT)

Follow NASDAQ:IKT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/21/2025
Buy
$1.26
90,000
$113K
90,000
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/21/2025
Buy
$1.26
5,834
$7K
5,834
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/21/2025
Sell
$3.79
5,834
$22K
0
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/21/2025
Sell
$2.16
90,000
$194K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Buy
$1.26
30,000
$38K
30,000
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Buy
$1.26
21,854
$28K
21,854
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Buy
$1.26
6,667
$8K
6,667
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Buy
$1.26
3,780
$5K
3,780
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Buy
$1.26
1,138
$1K
1,138
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$3.61
6,667
$24K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$1.54
30,000
$46K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$33.43
21,854
$731K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$60.00
1,138
$68K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$17.52
3,780
$66K
0
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/21/2025
Sell
$4.86
6,667
$32K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Buy
$1.26
45,000
$57K
45,000
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Buy
$1.26
35,000
$44K
35,000
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Buy
$1.26
30,000
$38K
30,000
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Buy
$1.26
21,854
$28K
21,854
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Buy
$1.26
20,834
$26K
20,834
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Buy
$1.26
16,667
$21K
16,667
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Buy
$1.26
6,667
$8K
6,667
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Buy
$1.26
3,780
$5K
3,780
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Buy
$1.26
3,643
$5K
3,643
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Buy
$1.26
1,138
$1K
1,138
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$60.00
1,138
$68K
0
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$17.52
3,780
$66K
0
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$4.86
6,667
$32K
0
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$3.61
6,667
$24K
0
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$1.54
30,000
$46K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$33.43
3,643
$122K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$13.86
3,643
$50K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$60.00
16,667
$1.000M
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$6.42
20,834
$134K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$4.44
35,000
$155K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$28.76
3,643
$105K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/21/2025
Sell
$2.16
45,000
$97K
0
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/21/2025
Sell
$33.43
21,854
$731K
0
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/03/2025
Buy
$1.26
5.32M
$6.697M
5.32M
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/03/2025
Buy
$1.58
4.06M
$6.414M
4.06M
NASDAQ IKT Inhibikase Therapeutics
Werner Milton H. / director, officer: President and CEO
01/03/2025
Buy
$1.45
2.21M
$3.201M
2.21M
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/03/2025
Buy
$1.26
470,861
$593K
470,861
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/03/2025
Buy
$1.58
432,853
$684K
432,853
NASDAQ IKT Inhibikase Therapeutics
Lees-Rolfe Garth / officer: Chief Financial Officer
01/03/2025
Buy
$1.45
235,383
$341K
235,383
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/03/2025
Buy
$1.26
344,452
$434K
344,452
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/03/2025
Buy
$1.58
316,647
$500K
316,647
NASDAQ IKT Inhibikase Therapeutics
Freeman Roy Lester / director
01/03/2025
Buy
$1.45
172,191
$250K
172,191
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/03/2025
Buy
$1.26
344,452
$434K
344,452
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/03/2025
Buy
$1.58
316,647
$500K
316,647
NASDAQ IKT Inhibikase Therapeutics
BERMAN DENNIS N / director
01/03/2025
Buy
$1.45
172,191
$250K
172,191

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous